Uso de Levosimendán en el postoperatorio de cirugía cardiaca.

48 Páginas.

Autores:
Tipo de recurso:
Fecha de publicación:
2010
Institución:
Universidad de la Sabana
Repositorio:
Repositorio Universidad de la Sabana
Idioma:
spa
OAI Identifier:
oai:intellectum.unisabana.edu.co:10818/7516
Acceso en línea:
https://hdl.handle.net/10818/7516
Palabra clave:
Corazón
Medicamentos
Rights
License
http://purl.org/coar/access_right/c_abf2
id REPOUSABAN_ea1db72cf74745b21d562ac26d11fb9f
oai_identifier_str oai:intellectum.unisabana.edu.co:10818/7516
network_acronym_str REPOUSABAN
network_name_str Repositorio Universidad de la Sabana
repository_id_str
dc.title.none.fl_str_mv Uso de Levosimendán en el postoperatorio de cirugía cardiaca.
title Uso de Levosimendán en el postoperatorio de cirugía cardiaca.
spellingShingle Uso de Levosimendán en el postoperatorio de cirugía cardiaca.
Corazón
Medicamentos
title_short Uso de Levosimendán en el postoperatorio de cirugía cardiaca.
title_full Uso de Levosimendán en el postoperatorio de cirugía cardiaca.
title_fullStr Uso de Levosimendán en el postoperatorio de cirugía cardiaca.
title_full_unstemmed Uso de Levosimendán en el postoperatorio de cirugía cardiaca.
title_sort Uso de Levosimendán en el postoperatorio de cirugía cardiaca.
dc.contributor.none.fl_str_mv Buitrago Bernal, Ricardo Antonio
dc.subject.none.fl_str_mv Corazón
Medicamentos
topic Corazón
Medicamentos
description 48 Páginas.
publishDate 2010
dc.date.none.fl_str_mv 2010
2010
2013-05-23T20:13:53Z
2013-05-23T20:13:53Z
dc.type.none.fl_str_mv Tesis/Trabajo de grado - Especialización
http://purl.org/coar/resource_type/c_7a1f
Texto
info:eu-repo/semantics/other
http://purl.org/redcol/resource_type/COther
info:eu-repo/semantics/acceptedVersion
status_str acceptedVersion
dc.identifier.none.fl_str_mv . Gillies M., Bellomo R, et al. Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery ¿ a systematic literature review. Crit Care. 2005 Jun;9(3):266- 79
Papp Z., Csapó K., et al. Pharmacological mechanisms contributing to the clinical efficacy of levosimendan. Cardiovasc Drug Rev. 2005 Spring; 23(1):71-98.
Nieminen MS, Böhm M, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Herat Failure of the Eur Heart J. 2008; 29: 2388 - 442
Raja S., Rayen B. Levosimendan in Cardiac Surgery: Current Best: Available Evidence. Ann Thorac Surg. 2006 Apr; 81(4):1536-46.
Salmenperä M, Eriksson H., et al. Levosimendan in perioperative and critical care patients. Curr Opin Anaesthesiol. 2009 Aug; 22(4):496-501.
Opie L. Braunwald Heart Disease Cardiovascular. 8a Edición, 2007. Capítulo 21: Mecanismos de la contracción y la relajación cardiaca
Cardiovascular Physiology. Lange. 5a Edición, 2005. Capítulo 2: Características de las células musculares cardiacas
Butler J, Giamouzis G, et al. A struggle to SURVIVE: to abandon or not to abandon levosimendan? Cardiovasc Drugs Ther 2007 Oct;21(5):401-2.
Archan S, Toller W, et al. Levosimendan: current status and future prospects. Curr Opin Anaesthesiol 2008 Feb;21(1):78-84.
Delaney A, Bradford C, et al. Levosimendan for the treatment of acute severe heart failure: A meta-analysis of randomised controlled trials. Int J Cardiol. 2010 Feb 4;138(3):281-9
Rehberg S, Ertmer C, et al. Role of Levosimendan in intensive care treatment of myocardial insufficiency. Anaesthesist 2007 Jan;56(1):30-43.
Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006 Mar;104(3):556-69.
Yildiz O. Vasodilating mechanisms of levosimendan: involvement of K+ channels. J Pharmacol Sci 2007 May;104(1):1-5.
Soedeing P. Inoprotection: the perioperative role of levosimendan. Anesth Intensive Care. 2007 Dec; 35(6):845-62.
Álvarez J., Taboada M., et al. Efectos hemodinámicos del levosimendan en el postoperatorio de pacientes sometidos a cirugía cardiaca. Rev Esp Anestesiol Reanim. 2005; 52: 389-94
Duygu H, Ozerkan F, et al. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure. Int J Clin Pract 2008 Feb;62(2):228-33.
Delle Karth G, Buberl A, et al. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand 2003 Nov;47(10):1251-6.
Russ MA, Prondzinsky R, et al. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 2007 Dec;35(12):2732-9.
Pinto, B., Rehberg S., et al. Role of levosimendan in sepsis and septic shock. Curr Opin Anesthesiol 2008 Apr;21(2):168-77.
Tritapepe L, De Santis V, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth 2006 Jun;96(6):694-700
De Hert SG, Lorsomradee S, et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007 Apr;104(4):766-73.
Tasouli A, Papadopoulos K, et al. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Eur J Cardiothorac Surg 2007 Oct;32(4):629-33.
Levin R., Degrange M. The Calcium Sensitizer Levosimendan Gives Superior Results to Dobutamine in Postoperative Low Cardiac Output Syndrome. Rev Esp Cardiol 2008 May;61(5):471-9.
Kerbaul F, Rondelet B, et al. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2006 Nov;34(11):2814-9.
Follath F, Cleland JG., et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart f Lancet 2002, Jul; 360(9328):196-202.
Moiseyev VS, Poder P., et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 2002 Sep;23(18):1422-32.
Johansson S, et al. Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study. Crit Care 2004; 8 Sup 1: 88.
Landoni G. et al. Reducing mortality in cardiac surgery with Levosimendan: A Meta-analysis of Randomized Controlled Trials. J Cardiothorac Vasc Anesth. 2010 Feb;24(1):51-7.
Aksun N, Karahan M. et al. Timing of levosimendan in cardiac surgery. Anadolu Kardiyol Derg. 2009 Jun;9(3):223-30.
De Santis V., Vitale D. et al. Levosimendan and cardiac surgery. Cardiothorac Vasc Anesth. 2010 Feb;24(1):210.
Nieminen MS, Pollesello P, et al. Effects of levosimendan on the energy balance: preclinical and clinical evidence. J Cardiovasc Pharmacol. 2009 Apr; 53(4):302-10.
https://hdl.handle.net/10818/7516
129265
TE01309
identifier_str_mv . Gillies M., Bellomo R, et al. Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery ¿ a systematic literature review. Crit Care. 2005 Jun;9(3):266- 79
Papp Z., Csapó K., et al. Pharmacological mechanisms contributing to the clinical efficacy of levosimendan. Cardiovasc Drug Rev. 2005 Spring; 23(1):71-98.
Nieminen MS, Böhm M, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Herat Failure of the Eur Heart J. 2008; 29: 2388 - 442
Raja S., Rayen B. Levosimendan in Cardiac Surgery: Current Best: Available Evidence. Ann Thorac Surg. 2006 Apr; 81(4):1536-46.
Salmenperä M, Eriksson H., et al. Levosimendan in perioperative and critical care patients. Curr Opin Anaesthesiol. 2009 Aug; 22(4):496-501.
Opie L. Braunwald Heart Disease Cardiovascular. 8a Edición, 2007. Capítulo 21: Mecanismos de la contracción y la relajación cardiaca
Cardiovascular Physiology. Lange. 5a Edición, 2005. Capítulo 2: Características de las células musculares cardiacas
Butler J, Giamouzis G, et al. A struggle to SURVIVE: to abandon or not to abandon levosimendan? Cardiovasc Drugs Ther 2007 Oct;21(5):401-2.
Archan S, Toller W, et al. Levosimendan: current status and future prospects. Curr Opin Anaesthesiol 2008 Feb;21(1):78-84.
Delaney A, Bradford C, et al. Levosimendan for the treatment of acute severe heart failure: A meta-analysis of randomised controlled trials. Int J Cardiol. 2010 Feb 4;138(3):281-9
Rehberg S, Ertmer C, et al. Role of Levosimendan in intensive care treatment of myocardial insufficiency. Anaesthesist 2007 Jan;56(1):30-43.
Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006 Mar;104(3):556-69.
Yildiz O. Vasodilating mechanisms of levosimendan: involvement of K+ channels. J Pharmacol Sci 2007 May;104(1):1-5.
Soedeing P. Inoprotection: the perioperative role of levosimendan. Anesth Intensive Care. 2007 Dec; 35(6):845-62.
Álvarez J., Taboada M., et al. Efectos hemodinámicos del levosimendan en el postoperatorio de pacientes sometidos a cirugía cardiaca. Rev Esp Anestesiol Reanim. 2005; 52: 389-94
Duygu H, Ozerkan F, et al. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure. Int J Clin Pract 2008 Feb;62(2):228-33.
Delle Karth G, Buberl A, et al. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand 2003 Nov;47(10):1251-6.
Russ MA, Prondzinsky R, et al. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 2007 Dec;35(12):2732-9.
Pinto, B., Rehberg S., et al. Role of levosimendan in sepsis and septic shock. Curr Opin Anesthesiol 2008 Apr;21(2):168-77.
Tritapepe L, De Santis V, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth 2006 Jun;96(6):694-700
De Hert SG, Lorsomradee S, et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007 Apr;104(4):766-73.
Tasouli A, Papadopoulos K, et al. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Eur J Cardiothorac Surg 2007 Oct;32(4):629-33.
Levin R., Degrange M. The Calcium Sensitizer Levosimendan Gives Superior Results to Dobutamine in Postoperative Low Cardiac Output Syndrome. Rev Esp Cardiol 2008 May;61(5):471-9.
Kerbaul F, Rondelet B, et al. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2006 Nov;34(11):2814-9.
Follath F, Cleland JG., et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart f Lancet 2002, Jul; 360(9328):196-202.
Moiseyev VS, Poder P., et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 2002 Sep;23(18):1422-32.
Johansson S, et al. Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study. Crit Care 2004; 8 Sup 1: 88.
Landoni G. et al. Reducing mortality in cardiac surgery with Levosimendan: A Meta-analysis of Randomized Controlled Trials. J Cardiothorac Vasc Anesth. 2010 Feb;24(1):51-7.
Aksun N, Karahan M. et al. Timing of levosimendan in cardiac surgery. Anadolu Kardiyol Derg. 2009 Jun;9(3):223-30.
De Santis V., Vitale D. et al. Levosimendan and cardiac surgery. Cardiothorac Vasc Anesth. 2010 Feb;24(1):210.
Nieminen MS, Pollesello P, et al. Effects of levosimendan on the energy balance: preclinical and clinical evidence. J Cardiovasc Pharmacol. 2009 Apr; 53(4):302-10.
129265
TE01309
url https://hdl.handle.net/10818/7516
dc.language.none.fl_str_mv spa
language spa
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv http://purl.org/coar/access_right/c_abf2
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad de La Sabana
Especialización en Medicina Crítica y Cuidado Intensivo
Facultad de Medicina
publisher.none.fl_str_mv Universidad de La Sabana
Especialización en Medicina Crítica y Cuidado Intensivo
Facultad de Medicina
dc.source.none.fl_str_mv Universidad de La Sabana
Intellectum Repositorio Universidad de La Sabana
institution Universidad de la Sabana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1860891751389069312
spelling Uso de Levosimendán en el postoperatorio de cirugía cardiaca.CorazónMedicamentos48 Páginas.Levosimendán es inotrópico y vasodilatador, con mecanismo de acción diferente, utilizado en falla cardiaca. En cirugía cardiaca la literatura es limitada, sin concluir efectividad e impacto en morbimortalidad. Este trabajo muestra el comportamiento hemodinámico y de perfusión tisular de pacientes con disfunción ventricular en postoperatorio, usando Levosimendán. 78 pacientes recibieron infusión de 0.1 mcg/kg/min; se recolectaron parámetros hemodinámicos y de perfusión tisular antes, durante y al finalizar la infusión para análisis descriptivo. Se observó aumento en índice cardiaco, disminución en presión capilar pulmonar; aumento en saturación venosa de oxígeno, disminución en Da-vO2, delta de CO2, tasa de extracción y base exceso. En este grupo de pacientes se observó mejoría en perfil hemodinámico y perfusión tisular, tras la infusión.Universidad de La SabanaEspecialización en Medicina Crítica y Cuidado IntensivoFacultad de MedicinaBuitrago Bernal, Ricardo AntonioHernández Parra, Ángela2013-05-23T20:13:53Z2013-05-23T20:13:53Z20102010Tesis/Trabajo de grado - Especializaciónhttp://purl.org/coar/resource_type/c_7a1fTextoinfo:eu-repo/semantics/otherhttp://purl.org/redcol/resource_type/COtherinfo:eu-repo/semantics/acceptedVersionapplication/pdf. Gillies M., Bellomo R, et al. Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery ¿ a systematic literature review. Crit Care. 2005 Jun;9(3):266- 79Papp Z., Csapó K., et al. Pharmacological mechanisms contributing to the clinical efficacy of levosimendan. Cardiovasc Drug Rev. 2005 Spring; 23(1):71-98.Nieminen MS, Böhm M, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Herat Failure of the Eur Heart J. 2008; 29: 2388 - 442Raja S., Rayen B. Levosimendan in Cardiac Surgery: Current Best: Available Evidence. Ann Thorac Surg. 2006 Apr; 81(4):1536-46.Salmenperä M, Eriksson H., et al. Levosimendan in perioperative and critical care patients. Curr Opin Anaesthesiol. 2009 Aug; 22(4):496-501.Opie L. Braunwald Heart Disease Cardiovascular. 8a Edición, 2007. Capítulo 21: Mecanismos de la contracción y la relajación cardiacaCardiovascular Physiology. Lange. 5a Edición, 2005. Capítulo 2: Características de las células musculares cardiacasButler J, Giamouzis G, et al. A struggle to SURVIVE: to abandon or not to abandon levosimendan? Cardiovasc Drugs Ther 2007 Oct;21(5):401-2.Archan S, Toller W, et al. Levosimendan: current status and future prospects. Curr Opin Anaesthesiol 2008 Feb;21(1):78-84.Delaney A, Bradford C, et al. Levosimendan for the treatment of acute severe heart failure: A meta-analysis of randomised controlled trials. Int J Cardiol. 2010 Feb 4;138(3):281-9Rehberg S, Ertmer C, et al. Role of Levosimendan in intensive care treatment of myocardial insufficiency. Anaesthesist 2007 Jan;56(1):30-43.Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006 Mar;104(3):556-69.Yildiz O. Vasodilating mechanisms of levosimendan: involvement of K+ channels. J Pharmacol Sci 2007 May;104(1):1-5.Soedeing P. Inoprotection: the perioperative role of levosimendan. Anesth Intensive Care. 2007 Dec; 35(6):845-62.Álvarez J., Taboada M., et al. Efectos hemodinámicos del levosimendan en el postoperatorio de pacientes sometidos a cirugía cardiaca. Rev Esp Anestesiol Reanim. 2005; 52: 389-94Duygu H, Ozerkan F, et al. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure. Int J Clin Pract 2008 Feb;62(2):228-33.Delle Karth G, Buberl A, et al. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand 2003 Nov;47(10):1251-6.Russ MA, Prondzinsky R, et al. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 2007 Dec;35(12):2732-9.Pinto, B., Rehberg S., et al. Role of levosimendan in sepsis and septic shock. Curr Opin Anesthesiol 2008 Apr;21(2):168-77.Tritapepe L, De Santis V, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth 2006 Jun;96(6):694-700De Hert SG, Lorsomradee S, et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007 Apr;104(4):766-73.Tasouli A, Papadopoulos K, et al. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Eur J Cardiothorac Surg 2007 Oct;32(4):629-33.Levin R., Degrange M. The Calcium Sensitizer Levosimendan Gives Superior Results to Dobutamine in Postoperative Low Cardiac Output Syndrome. Rev Esp Cardiol 2008 May;61(5):471-9.Kerbaul F, Rondelet B, et al. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2006 Nov;34(11):2814-9.Follath F, Cleland JG., et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart f Lancet 2002, Jul; 360(9328):196-202.Moiseyev VS, Poder P., et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 2002 Sep;23(18):1422-32.Johansson S, et al. Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study. Crit Care 2004; 8 Sup 1: 88.Landoni G. et al. Reducing mortality in cardiac surgery with Levosimendan: A Meta-analysis of Randomized Controlled Trials. J Cardiothorac Vasc Anesth. 2010 Feb;24(1):51-7.Aksun N, Karahan M. et al. Timing of levosimendan in cardiac surgery. Anadolu Kardiyol Derg. 2009 Jun;9(3):223-30.De Santis V., Vitale D. et al. Levosimendan and cardiac surgery. Cardiothorac Vasc Anesth. 2010 Feb;24(1):210.Nieminen MS, Pollesello P, et al. Effects of levosimendan on the energy balance: preclinical and clinical evidence. J Cardiovasc Pharmacol. 2009 Apr; 53(4):302-10.https://hdl.handle.net/10818/7516129265TE01309Universidad de La SabanaIntellectum Repositorio Universidad de La Sabanaspahttp://purl.org/coar/access_right/c_abf2oai:intellectum.unisabana.edu.co:10818/75162025-12-11T18:35:07Z

Publicaciones similares